-
A consortium of 10 pediatric hospitals in Bangladesh, Egypt, Malawi, Pakistan, and Vietnam was assembled by the World Health Organization CSF5 study group with funding from the U.S. Agency for International Development to compare 5 days vs. 10 days of therapy with ceftriaxone.
-
The United States Perinatal HIV Surveillance Project tracks HIV-infected pregnant women in care in 15 locations throughout the United States and Puerto Rico.
-
By 2007, the prevalence of fluoroquinolone resistance among N. gonorrhoeae had become so widespread in the United States that the CDC recommended against use of drugs of that class in the treatment of gonorrhea.
-
-
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection (OI) in AIDS patients. Laboratory diagnosis of this life-threatening infection is based primarily upon identifying P. jirovecii cysts in respiratory secretions, a technique that is variably sensitive and requires adequate patient effort (for induced sputum examination) or an invasive test (bronchoscopy); both are quite operator dependent.
-
Seven patients were identified when DAP-ASBL therapy was used to eradicate persistent MRSA bacteremia. Isolates from 3 patients were available for in vitro study.
-
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.
-
The National Medication Error Reporting Program (operated by the Institute for Safe Medication Practices [ISMP]) recently issued an alert on the potential risk of medication errors associated with dosing colistimethate for injection.
-
The American Medical Association convened the biannual House of Delegates meeting in Chicago in June with more than 500 delegates from a variety of societies and organizations.
-
The increasing sophistication of molecular tools is allowing for the discovery of all kinds of novel strains of bacteria; witness the multiple new strains of Rickettsia discovered around the world.
